TOBEMSTOMIG
UNII 93NRF4S9HR

Substance Identification & Data

This profile provides standardized clinical and technical data for Tobemstomig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 93NRF4S9HR.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2648839-43-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

93NRF4S9HR

CAS Registry Number

2648839-43-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TOBEMSTOMIG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C173539

National Cancer Institute reference terminology for clinical and research data.

INN ID

12318

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-153

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tobemstomig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TOBEMSTOMIG

Common Names & Synonyms

IMMUNOGLOBULIN G1 (151-GLUTAMIC ACID,217-GLUTAMIC ACID,236-ALANINE,237-ALANINE,331-GLYCINE,351-CYSTEINE,368-SERINE,370-ALANINE,409-VALINE), ANTI-(HUMAN LYMPHOCYTE ACTIVATION GENE-3 PROTEIN) (HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL LAG3-0414 .GAMMA.1-CHAIN), DISULFIDE WITH (123-ARGININE,124-LYSINE) (HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL LAG3-0414 .KAPPA.-CHAIN), (230->222'),(233->225'),(353->350')-TRIS(DISULFIDE) WITH IMMUNOGLOBULIN (ENDO-112-SERINE,ENDO-113-SERINE,230-ALANINE,231-ALANINE,325-GLYCINE,350-CYSTEINE,362-TRYPTOPHAN) ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS MONOCLONAL PD1-0376 .KAPPA.-CHAIN V-J REGION) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN C REGION) DISULFIDE WITH IMMUNOGLOBULIN ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS MONOCLONAL PD1-0376 HEAVY CHAIN V-D-J REGION) FUSION PROTEIN WITH IMMUNOGLOBULIN (HUMAN .KAPPA.-CHAIN C REGION)

IMMUNOGLOBULIN G1-KAPPA WITH CROSSED DOMAINS, ANTI-(HOMO SAPIENS PDCD1 (PROGRAMMED CELL DEATH 1, PD1, PD-1, CD279)) AND ANTI-(HOMO SAPIENS LAG3 (LYMPHOCYTE ACTIVATING 3, LYMPHOCYTE-ACTIVATION 3, CD223)), HUMANIZED MONOCLONAL ANTIBODY, BISPECIFIC

TOBEMSTOMIG [INN]

TOBEMSTOMIG [USAN]

TOBEMSTOMIG [WHO-DD]